PCN48 THE COST-EFFECTIVENESS OF BORTEZOMIB FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA IN SWEDEN
May 1, 2009, 00:00 AM
10.1016/S1098-3015(10)73285-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)73285-X/fulltext
Section Title :
Section Order :
713
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73285-X&doi=10.1016/S1098-3015(10)73285-X